Drug intelligence / Profile preview

etofenamate

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Topical, Intramuscular
01

Overview

Etofenamate is a nonsteroidal anti-inflammatory drug (NSAID) of the flufenamic acid derivative group used primarily for the topical treatment of joint and muscular pain. It is available as a cream, gel, or spray for local application and can also be administered intramuscularly in some settings. Etofenamate exerts its effects by inhibiting both cyclooxygenase (COX) and lipoxygenase enzymes, thereby reducing prostaglandin and leukotriene synthesis. This dual inhibition results in analgesic and anti-inflammatory properties. Additionally, etofenamate inhibits other inflammatory mediators such as histamine release, bradykinin antagonism, serotonin antagonism, complement system activity inhibition, and hyaluronidase inhibition[5][6][7]. It is indicated for localized painful conditions of the musculoskeletal system including arthropathies (joint diseases), myalgias (muscle pain), bursitis (inflammation of fluid-filled sacs around joints), neuralgia (nerve pain), contusions (bruises), strains or sprains[5]. Due to poor oral bioavailability it is not administered orally[6].

Brand names
RheumonTraumonFlexagil
Other names
etofenamate
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on etofenamate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on etofenamate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call